- Growing attention to an old marker, hepatitis B surface antigen, in the natural history of chronic hepatitis B
-
Jang JW
- KMID: 1717333
- Korean J Hepatol.
- 2010 Sep;16(3):342-346.
- doi: 10.3350/kjhep.2010.16.3.342
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Massive hepatic necrosis with large regenerative nodules
-
Kim H, Park YN
- KMID: 1717331
- Korean J Hepatol.
- 2010 Sep;16(3):334-337.
- doi: 10.3350/kjhep.2010.16.3.334
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatic adrenal rest tumor mimicking hepatocellular carcinoma
-
Shin YM
- KMID: 1717332
- Korean J Hepatol.
- 2010 Sep;16(3):338-341.
- doi: 10.3350/kjhep.2010.16.3.338
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Hypoxia-inducible factor 1, hepatocellular carcinoma and angiogenesis
-
Kim JW
- KMID: 1717321
- Korean J Hepatol.
- 2010 Sep;16(3):278-279.
- doi: 10.3350/kjhep.2010.16.3.278
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical courses after administration of oral corticosteroids in patients with severely cholestatic acute hepatitis A; three cases
-
Yoon EL, Yim HJ, Kim SY, Kim JH, Lee JH, Lee YS, Lee HJ, Jung SW, Lee SW, Choi JH
- KMID: 1717330
- Korean J Hepatol.
- 2010 Sep;16(3):329-333.
- doi: 10.3350/kjhep.2010.16.3.329
Acute hepatitis A is currently outbreaking in Korea. Although prognosis of acute hepatitis A is generally favorable, a minority of patients are accompanied by fatal complications. Severe cholestasis is one... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of concomitant Gilbert's syndrome and hereditary spherocytosis
-
Lee HJ, Moon HS, Lee ES, Kim SH, Sung JK, Lee BS, Jeong HY, Lee HY, Eu YJ
- KMID: 1717328
- Korean J Hepatol.
- 2010 Sep;16(3):321-324.
- doi: 10.3350/kjhep.2010.16.3.321
We describe moderate hyperbilirubinemia in a 28-year-old man who suffered from gallstones and splenomegaly, with combined disorders of hereditary spherocytosis (HS) and Gilbert's syndrome (GS). Since it is difficult to... -
- CITED
-
- Close
- SHARE
-
- Close
- New treatments for chronic hepatitis C
-
Jang JY, Chung RT
- KMID: 1717320
- Korean J Hepatol.
- 2010 Sep;16(3):263-277.
- doi: 10.3350/kjhep.2010.16.3.263
Treatments for chronic hepatitis C has evolved significantly in the past 15 years. The standard of care (SOC) is peginterferon alfa-2a/-2b with ribavirin for 48 weeks or 24 weeks in... -
- CITED
-
- Close
- SHARE
-
- Close
- Factors influencing the severity of acute viral hepatitis A
-
Kim JI, Kim YS, Jung YK, Kwon OS, Kim YS, Ku YS, Choi DJ, Kim JH
- KMID: 1717324
- Korean J Hepatol.
- 2010 Sep;16(3):295-300.
- doi: 10.3350/kjhep.2010.16.3.295
BACKGROUND/AIMS: Most patients with acute viral hepatitis A have a favorable course, but a few of them suffer from severe forms of hepatitis such as fulminant hepatitis. This study was... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum prohepcidin levels in chronic hepatitis C, alcoholic liver disease, and nonalcoholic fatty liver disease
-
Lee SH, Jeong SH, Park YS, Hwang JH, Kim JW, Kim N, Lee DH
- KMID: 1717323
- Korean J Hepatol.
- 2010 Sep;16(3):288-294.
- doi: 10.3350/kjhep.2010.16.3.288
BACKGROUND/AIMS: Patients with various chronic liver diseases frequently have increased body iron stores. Prohepcidin is an easily measurable precursor of hepcidin, which is a key regulator of iron homeostasis. This... -
- CITED
-
- Close
- SHARE
-
- Close
- Detection of distant metastasis to skeletal muscle by 18F-FDG-PET in a case of intrahepatic cholangiocarcinoma
-
Park SK, Kim YS, Kim SG, Jang JY, Moon JH, Lee MS, Kim BS, Koh ES, Park JM
- KMID: 1717329
- Korean J Hepatol.
- 2010 Sep;16(3):325-328.
- doi: 10.3350/kjhep.2010.16.3.325
Intrahepatic cholangiocarcinoma is a rare malignancy that originates from the epithelial cells of the intrahepatic bile ducts. Intrahepatic cholangiocarcinoma can metastasize in lymphatic chains, including the hepatoduodenal ligament, and it... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis
-
Chung MY, Jun DW, Sung SA
- KMID: 1717325
- Korean J Hepatol.
- 2010 Sep;16(3):301-307.
- doi: 10.3350/kjhep.2010.16.3.301
BACKGROUND/AIMS: The present study aimed to determine the role of cystatin C as a prognostic factor for acute kidney injury and survival in cirrhotic patients. METHODS: The study investigated 53... -
- CITED
-
- Close
- SHARE
-
- Close
- Forty-eight weeks treatment with clevudine 30 mg qd versus lamivudine 100 mg qd for chronic hepatitis B infection: a double-blind randomized study
-
Lau GK, Leung N
- KMID: 1717327
- Korean J Hepatol.
- 2010 Sep;16(3):315-320.
- doi: 10.3350/kjhep.2010.16.3.315
BACKGROUND/AIMS: Clevudine is a pyrimidine analogue with potent activity against hepatitis B virus (HBV) replication in vitro. In a previous pivotal phase III clinical study, 24 weeks treatment with clevudine... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of alcohol on the development of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis: a cross-sectional case-control study
-
Kwon OS, Jung YK, Kim YS, Kim SG, Kim YS, Lee JI, Lee JW, Kim YS, Chun BC, Kim JH
- KMID: 1717326
- Korean J Hepatol.
- 2010 Sep;16(3):308-314.
- doi: 10.3350/kjhep.2010.16.3.308
BACKGROUND/AIMS: Whether alcohol intake increases the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV) infection remains controversial. The aim of this study was to determine... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of the knockdown of hypoxia inducible factor-1alpha expression by adenovirus-mediated shRNA on angiogenesis and tumor growth in hepatocellular carcinoma cell lines
-
Choi SH, Shin HW, Park JY, Yoo JY, Kim DY, Ro WS, Yun CO, Han KH
- KMID: 1717322
- Korean J Hepatol.
- 2010 Sep;16(3):280-287.
- doi: 10.3350/kjhep.2010.16.3.280
BACKGROUND/AIMS: Hypoxia-inducible factor-1alpha (HIF-1alpha) is a central transcriptional factor involved in the cellular responses related to various aspects of cancer biology, including proliferation, survival, and angiogenesis, and the metabolism of... -
- CITED
-
- Close
- SHARE
-
- Close
